4LL9
 
 | | Crystal structure of D3D4 domain of the LILRB1 molecule | | Descriptor: | IODIDE ION, Leukocyte immunoglobulin-like receptor subfamily B member 1 | | Authors: | Nam, G, Shi, Y, Ryu, M, Wang, Q, Song, H, Liu, J, Yan, J, Qi, J, Gao, G.F. | | Deposit date: | 2013-07-09 | | Release date: | 2013-09-11 | | Last modified: | 2024-10-30 | | Method: | X-RAY DIFFRACTION (2.686 Å) | | Cite: | Crystal structures of the two membrane-proximal Ig-like domains (D3D4) of LILRB1/B2: alternative models for their involvement in peptide-HLA binding
Protein Cell, 4, 2013
|
|
1KAK
 | | Human Tyrosine Phosphatase 1B Complexed with an Inhibitor | | Descriptor: | PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1, {[7-(DIFLUORO-PHOSPHONO-METHYL)-NAPHTHALEN-2-YL]-DIFLUORO-METHYL}-PHOSPHONIC ACID | | Authors: | Jia, Z, Ye, Q, Dinaut, A.N, Wang, Q, Waddleton, D, Payette, P, Ramachandran, C, Kennedy, B, Hum, G, Taylor, S.D. | | Deposit date: | 2001-11-02 | | Release date: | 2002-06-19 | | Last modified: | 2023-08-16 | | Method: | X-RAY DIFFRACTION (2.5 Å) | | Cite: | Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics.
J.Med.Chem., 44, 2001
|
|
1KAV
 | | Human Tyrosine Phosphatase 1B Complexed with an Inhibitor | | Descriptor: | PROTEIN-TYROSINE PHOSPHATASE, NON-RECEPTOR TYPE 1, [(4-{4-[4-(DIFLUORO-PHOSPHONO-METHYL)-PHENYL]-BUTYL}-PHENYL)-DIFLUORO-METHYL]-PHOSPHONIC ACID | | Authors: | Jia, Z, Ye, Q, Dinaut, A.N, Wang, Q, Waddleton, D, Payette, P, Ramachandran, C, Kennedy, B, Hum, G, Taylor, S.D. | | Deposit date: | 2001-11-03 | | Release date: | 2002-06-19 | | Last modified: | 2023-08-16 | | Method: | X-RAY DIFFRACTION (2.35 Å) | | Cite: | Structure of protein tyrosine phosphatase 1B in complex with inhibitors bearing two phosphotyrosine mimetics.
J.Med.Chem., 44, 2001
|
|
7ORW
 | | Non-structural protein 10 (nsp10) from SARS CoV-2 in complex with fragment VT00265 | | Descriptor: | 1H-benzimidazol-4-amine, CHLORIDE ION, DIMETHYL SULFOXIDE, ... | | Authors: | Talibov, V.O, Kozielski, F, Sele, C, Lou, J, Dong, D, Wang, Q, Shi, X, Nyblom, M, Rogstam, A, Krojer, T, Knecht, W, Fisher, S.Z. | | Deposit date: | 2021-06-06 | | Release date: | 2021-10-20 | | Last modified: | 2024-01-31 | | Method: | X-RAY DIFFRACTION (1.95 Å) | | Cite: | Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16.
Rsc Chem Biol, 3, 2022
|
|
7ORU
 | | Non-structural protein 10 (nsp10) from SARS CoV-2 in complex with fragment VT00221 | | Descriptor: | CHLORIDE ION, DIMETHYL SULFOXIDE, GLYCEROL, ... | | Authors: | Talibov, V.O, Kozielski, F, Sele, C, Lou, J, Dong, D, Wang, Q, Shi, X, Nyblom, M, Rogstam, A, Krojer, T, Knecht, W, Fisher, S.Z. | | Deposit date: | 2021-06-06 | | Release date: | 2021-10-20 | | Last modified: | 2024-01-31 | | Method: | X-RAY DIFFRACTION (1.67 Å) | | Cite: | Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16.
Rsc Chem Biol, 3, 2022
|
|
7ORV
 | | Non-structural protein 10 (nsp10) from SARS CoV-2 in complex with fragment VT00239 | | Descriptor: | CHLORIDE ION, DIMETHYL SULFOXIDE, GLYCEROL, ... | | Authors: | Talibov, V.O, Kozielski, F, Sele, C, Lou, J, Dong, D, Wang, Q, Shi, X, Nyblom, M, Rogstam, A, Krojer, T, Knecht, W, Fisher, S.Z. | | Deposit date: | 2021-06-06 | | Release date: | 2021-10-20 | | Last modified: | 2024-01-31 | | Method: | X-RAY DIFFRACTION (1.95 Å) | | Cite: | Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16.
Rsc Chem Biol, 3, 2022
|
|
7ORR
 | | Non-structural protein 10 (nsp10) from SARS CoV-2 in complex with fragment VT00022 | | Descriptor: | 4-PHENYL-1H-IMIDAZOLE, CHLORIDE ION, DIMETHYL SULFOXIDE, ... | | Authors: | Talibov, V.O, Kozielski, F, Sele, C, Lou, J, Dong, D, Wang, Q, Shi, X, Nyblom, M, Rogstam, A, Krojer, T, Knecht, W, Fisher, S.Z. | | Deposit date: | 2021-06-06 | | Release date: | 2021-10-20 | | Last modified: | 2024-01-31 | | Method: | X-RAY DIFFRACTION (1.79 Å) | | Cite: | Identification of fragments binding to SARS-CoV-2 nsp10 reveals ligand-binding sites in conserved interfaces between nsp10 and nsp14/nsp16.
Rsc Chem Biol, 3, 2022
|
|
8DOL
 | | Mechanism of regulation of the Helicobacter pylori Cagbeta ATPase by CagZ | | Descriptor: | Cag pathogenicity island protein (Cag5), DI(HYDROXYETHYL)ETHER, SULFATE ION | | Authors: | Wu, X, Zhao, Y, Yang, W, Sun, L, Ye, X, Jiang, M, Wang, Q, Wang, Q, Zhang, X, Wu, Y. | | Deposit date: | 2022-07-13 | | Release date: | 2023-02-15 | | Last modified: | 2024-04-03 | | Method: | X-RAY DIFFRACTION (2.8 Å) | | Cite: | Mechanism of regulation of the Helicobacter pylori Cag beta ATPase by CagZ.
Nat Commun, 14, 2023
|
|
7H9O
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13146 | | Descriptor: | Heat shock protein HSP 90-alpha, {4-[(oxan-4-yl)oxy]phenyl}methanol | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.55 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HB6
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13755 | | Descriptor: | 5-fluoranyl-1~{H}-indole-2,3-dione, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (2.09 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HBK
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13232 | | Descriptor: | 6-(2,3-dimethylphenoxy)pyridin-3-amine, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (2.14 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HC1
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with 10T-0263 | | Descriptor: | (3M)-3-(3-fluoro-4-methoxyphenyl)-4-methyl-1H-pyrazole, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (2.13 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7H9V
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr12319 | | Descriptor: | 8-carbamoyl-1-benzopyran-1-ium, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.52 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7H9W
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr12314 | | Descriptor: | 3,4-dihydro-2~{H}-chromene-6-carboxamide, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.64 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HA0
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr12546 | | Descriptor: | 3-(pyridin-2-yloxy)aniline, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.47 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7H9R
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr14452 | | Descriptor: | Heat shock protein HSP 90-alpha, N-(3-ethynylphenyl)acetamide | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.69 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HA7
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with PS-5947 | | Descriptor: | 4-bromo-3-[(dimethylamino)methyl]phenol, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (2.27 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HAN
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with PS-3286 | | Descriptor: | (2P)-2-(1H-pyrazol-4-yl)pyrazine, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.61 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HBR
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with AS-5576 | | Descriptor: | 4-(4-fluorophenyl)-1H-pyrazole, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.91 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7H9P
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr12541 | | Descriptor: | 4-phenoxyphenol, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.64 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7H9S
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with FS-3027 | | Descriptor: | Heat shock protein HSP 90-alpha, [2-(4-ethylpiperazin-1-yl)phenyl]methanol | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (2.17 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HBM
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr13278 | | Descriptor: | Heat shock protein HSP 90-alpha, N-cycloheptyl-N'-(2-hydroxyethyl)thiourea | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (2.21 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HBY
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with 9R-0342 | | Descriptor: | Heat shock protein HSP 90-alpha, N-[(4-fluorophenyl)methyl]-1H-pyrrole-2-carboxamide | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.82 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7H9Y
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with NH-0224 | | Descriptor: | 1-[5-chloro-4-(difluoromethyl)pyridin-2-yl]piperazine, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (2.11 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
7HB0
 | | PanDDA analysis group deposition -- Crystal structure of HSP90N in complex with Fr12780 | | Descriptor: | 2-[(oxan-4-yl)oxy]aniline, Heat shock protein HSP 90-alpha | | Authors: | Huang, L, Wang, W, Zhu, Z, Li, Q, Li, M, Zhou, H, Xu, Q, Wen, W, Wang, Q, Yu, F. | | Deposit date: | 2024-07-10 | | Release date: | 2025-03-26 | | Method: | X-RAY DIFFRACTION (1.78 Å) | | Cite: | Novel starting points for fragment-based drug design against human heat-shock protein 90 identified using crystallographic fragment screening.
Iucrj, 12, 2025
|
|
